Evidence map›Paper›PMID 40457486›Full record

ArticleStem cell research & therapy2025

circ_0002456/FUS interaction inhibits NF-κB signaling to attenuate DNA damage and inflammatory responses in hDPSCs.

Liecong Lin, Huixian Dong, Feng Lai, Jingkun Zhang, Bingtao Wang, Xiaohui Lv, Li Lin, Kehuan Hong, Yuxuan Zhao, Qianzhou Jiang

Erratum issuedAbstract read
In one paragraph

Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Liecong Lin *Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Huixian Dong *Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Feng LaiKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Jingkun ZhangKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Bingtao WangKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Xiaohui LvKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Li LinKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Kehuan HongKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Yuxuan ZhaoKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China.
Qianzhou JiangKey Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medical University, Huangsha Avenue 39, Guangzhou, 510000, People's Republic of China. jqianzhou@126.com.ORCID http://orcid.org/0000-0003-2631-7527

Funding

Basic and Applied Basic Research Foundation of Guangdong Province no.2022A1515111150Basic and Applied Basic Research Foundation of Guangdong Province no.2024A1515012741National Natural Science Foundation of China no. 82270966
6 · The paper itself

Abstract

objectivescircular RNAs (circRNAs) are emerging regulators of inflammatory diseases, but their role in pulpitis remains unclear. This study aimed to investigate the role of circRNA in the occurrence and development of pulpitis.

methodsqRT-PCR and Western Blot were used to detect γ-H2AX, a marker of DNA double-strand breaks (DSBs), and inflammatory factors in pulp tissues. Bioinformatics identified dysregulated circRNAs. Loss- and gain-of-function experiments were conducted to explore the function of circ_0002456 in lipopolysaccharide (LPS)-induced DNA damage and inflammation in human dental pulp stem cells (hDPSCs). The interaction between circ_0002456 and fused in sarcoma (FUS) protein was validated by RNA fluorescence in situ hybridization (FISH), RNA pull-down and nucleoplasmic separation experimen. NF-κB pathway activation was assessed after circ_0002456/FUS siRNA transfection in hDPSCs, and NF-κB inhibitors were used to confirm its regulatory role in DNA damage and inflammation.

resultsDNA damage was positively correlated with inflammation in pulpitis. In vitro, circ_0002456 downregulation exacerbated LPS-induced DNA damage and inflammation, while overexpression alleviated these effects. Mechanistically, circ_0002456 bound FUS, restricting its nuclear export and suppressing NF-κB activation, thereby mitigating DNA damage and inflammation.

conclusioncirc_0002456 interacts with FUS to inhibit NF-κB signaling, attenuating DNA damage and inflammation in hDPSCs, revealing a novel regulatory axis in pulpitis.

Indexed as

Dental PulpDNA DamageInflammationNF-kappa BPulpitisRNA, CircularStem CellsHumansLipopolysaccharidesSignal TransductionLipopolysaccharidesNF-kappa BRNA, CircularCircRNADNA damageFUSNF-κBPulpitis

Identifiers

PMID40457486
PMCPMC12131344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.